HealthcareServices

Osteoarthritis Market Anticipated to Record Steady Gains, Advancing to $11.91 Billion by 2030

February 27, 2026March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the osteoarthritis market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Osteoarthritis Market in 2030?

The osteoarthritis market has experienced robust expansion in recent years. It is anticipated to grow from $7.49 billion in 2025 to $8.16 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.9%. Historically, this market’s upward trend is attributable to the increasing global occurrence of osteoarthritis, the constrained availability of advanced joint therapies in earlier stages, a rising aging demographic suffering from joint degeneration, the initial adoption of conventional medications and surgical interventions, and an increased understanding of joint well-being and pain management.

The osteoarthritis market is set for substantial growth in the upcoming years, with its size projected to reach $11.92 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.9%. This expansion during the forecast period is attributable to several factors, including the increasing adoption of minimally invasive and robotic-assisted surgeries, the rising use of biologics and DMOADs, the expansion of healthcare infrastructure dedicated to joint care, the growing implementation of digital diagnostics and AI-based monitoring, and enhanced patient awareness regarding lifestyle and weight management programs. Key trends expected over the forecast period involve the increasing uptake of minimally invasive joint replacement surgeries, the greater application of biologic therapies and hyaluronic acid injections, the broadening integration of digital imaging and AI-powered diagnostics, a heightened focus on personalized osteoarthritis management plans, and increased investment in physical therapy and rehabilitation programs.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13022&type=smp

What Drivers Are Influencing Production Trends In The Osteoarthritis Market?

The projected increase in obesity-related health conditions is anticipated to fuel the growth of the osteoarthritis market moving forward. Problems connected to obesity refer to a variety of health issues that can result from excessive body fat. This condition arises from consuming more calories than the body expends through physical activity and exercise, along with eating substantial amounts of processed or fast food, and excessive alcohol intake. Obesity can lead to osteoarthritis by exerting strain on joints, generating inflammation, and altering hormones, thereby increasing the load on these joints. For instance, in September 2024, according to the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, the number of states where adult obesity prevalence was 35% or higher rose from 22 states in 2022 to 23 states in 2023. Thus, the rising incidence of obesity-related disorders is stimulating the expansion of the osteoarthritis market.

Which Segment Groups Are Influencing The Osteoarthritis Market?

The osteoarthritis market covered in this report is segmented –

1) By Treatment: Medication, Surgery, Therapy

2) By Diagnosis: Imaging, Joint Fluid Analysis

3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route

4) By Disease Type: Knee Osteoarthritis, Spine Osteoarthritis, Foot And Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis

5) By End-User: Hospitals, Medical Institutes

Subsegments:

1) By Medication: Pain Relievers, Corticosteroids, Hyaluronic Acid Injections, Disease-Modifying Osteoarthritis Drugs (DMOADs)

2) By Surgery: Joint Replacement Surgery, Arthroscopy, Osteotomy, Joint Fusion

3) By Therapy: Physical Therapy, Occupational Therapy, Weight Management Programs, Assistive Devices

Which Market Trends Are Opening Growth Opportunities In The Osteoarthritis Market?

Companies operating significantly in the osteoarthritis market are increasingly adopting a strategic partnership approach to improve technology integration and broaden their market reach. Such a partnership generally signifies a collaborative relationship between two or more entities, wherein they combine their resources, expertise, and efforts to achieve shared goals or objectives. For instance, in July 2024, LG Chem, a pharmaceutical company based in South Korea, entered the Chinese market through a partnership with Yifan Pharmaceutical Co., Ltd., a China-based pharmaceutical research and production company. This collaboration aims to launch Synovian injection for osteoarthritis, offering therapeutic effects similar to traditional multi-injection formulations but with only one administration. Key characteristics of Synovian include its high molecular weight (10 million Dalton) hyaluronic acid, which enhances viscoelasticity and joint function, and its proven capacity to significantly lessen knee pain, according to clinical phase 3 trial results. This development establishes Synovian as an effective choice for patients looking for convenient relief from osteoarthritis symptoms.

Who Are The Prominent Global Companies Shaping The Osteoarthritis Market Landscape?

Major companies operating in the osteoarthritis market are Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics plc, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

Which Region Is Projected To Lead The Osteoarthritis Market During The Forecast Period?

North America was the largest region in the osteoarthritis market in 2025. The regions covered in the osteoarthritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Osteoarthritis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13022&type=smp

Browse Through More Reports Similar to the Global Osteoarthritis Market 2026, By The Business Research Company

Osteoporosis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

Axial Spondyloarthritis Axspa Market Report 2026

https://www.thebusinessresearchcompany.com/report/axial-spondyloarthritis-axspa-global-market-report

Gouty Arthritis Market Report 2026

https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795